Effect of ?-3 fatty acids on gastric cancer patients
Phase 2
- Conditions
- Gastric cancer patients undergoing chemotherapy.Malignant neoplasm of stomach
- Registration Number
- IRCT201011095144N1
- Lead Sponsor
- utririon research center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Patients with gastric cancer in phase 3 (cardia and non cardia) during chemotherapy over 30 years old.
Exclusion criteria: other diseases induced cachexia such as heart disease, lung, AIDS, renal disease, incidence of acute leukemia, diabetes and multiple myeloma, individauls undergoing surgery and who do not take the given drugs properly during the study period.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Weight. Timepoint: days of 0, 30 and 45. Method of measurement: digital scale.
- Secondary Outcome Measures
Name Time Method